Close
Smartlab Europe
Inizio Ignite

Press Releases

World’s Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19

Three members of the COVID R&D Alliance - Amgen Inc., Takeda Pharmaceutical Co. Ltd. and UCB announced the first patient enrolled in the COMMUNITY Trial (COVID-19 Multiple Agents and Modulators Unified Industry Members). COMMUNITY is a randomized, double-blind, placebo-controlled,...

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies

Eisai Co., Ltd. and Wren Therapeutics Ltd. announced that the companies have entered into an exclusive research collaboration agreement aiming to advance the discovery of novel small molecules that target α-synuclein for the potential treatment of synucleinopathies including Parkinson’s...

Bayer establishes Cell and Gene Therapy Platform to accelerate pharmaceutical innovation

Bayer AG announced the launch of a Cell and Gene Therapy (C&GT) Platform within its Pharmaceuticals division. Through this strategic platform, the company further consolidates its emerging leadership in the field and takes a deeply transformative step for its...

DuPont Brings Science-backed Quality and Innovation to Asia’s Pharmaceutical Industry at CPhI China 2020

DuPont Nutrition & Biosciences (DuPont) will use insights to help manufacturers evolve with the biggest trends in the Asia pharma industry, with highlights to the latest offerings at CPhI China 2020 from December 16–18. Attendees who visit DuPont booth...

Air France KLM Martinair Cargo partners withSkyCell to increase sustainability and safety of pharmaceutical shipments

SkyCell and Air France KLM Martinair Cargo have signed a partnership agreement. The agreement sets out the reintroduction of hybrid containers for those shipping with Air France KLM Martinair Cargo, supporting a push to increase the sustainability and safety...

Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person

Roche announced that the U.S. FDA has approved a supplemental New Drug Application (sNDA) for Xofluza® (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone with influenza (known...

Pelican BioThermal Expands Deep Frozen Product Range to Meet COVID-19 Vaccine Shipping Requirements

Pelican BioThermal, the global name in temperature controlled packaging, announces deep frozen temperature controlled packaging options with temperature ranges of minus 80 degrees Celsius to minus 20 degrees Celsius. The new offerings help meet the growing need for increased...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »